Clinical Trial Results

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

PHASE1INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Lupus Landmark Study: A Prospective Registry and Biorepository

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

N/AOBSERVATIONAL Washington D.C., District of Columbia

RECRUITING

Research Accelerated by You Lupus Registry

N/AOBSERVATIONAL Washington D.C., District of Columbia

RECRUITING

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

PHASE1, PHASE2INTERVENTIONAL Washington D.C., District of Columbia +2 more

RECRUITING

Study of Systemic Lupus Erythematosus

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

PHASE2INTERVENTIONAL Bethesda, Maryland

RECRUITING

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

PHASE1, PHASE2INTERVENTIONAL Bethesda, Maryland

RECRUITING

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

PHASE1, PHASE2INTERVENTIONAL San Francisco, California +4 more

RECRUITING

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

PHASE1INTERVENTIONAL Bethesda, Maryland

RECRUITING

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

N/AOBSERVATIONAL Mesa, Arizona +4 more

RECRUITING

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

PHASE4INTERVENTIONAL La Mesa, California +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

PHASE3INTERVENTIONAL Avondale, Arizona +4 more

RECRUITING

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

N/AOBSERVATIONAL Baltimore, Maryland +4 more

RECRUITING

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

N/AOBSERVATIONAL Chicago, Illinois +4 more

RECRUITING

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

PHASE2INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

PHASE3INTERVENTIONAL Anniston, Alabama +4 more

RECRUITING